Investigating the Immune System in chrONIC Kidney Disease.
NCT02535052 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 43
Last updated 2016-05-16
Summary
This study will investigate the function of the immune system in people with chronic kidney disease (CKD) compared to people with normal kidneys. The investigators will use standard vaccines - the seasonal flu vaccine and pneumococcal polysaccharide (Pneumovax) vaccine - to examine how the immune system responds to challenge. All subjects will receive these recommended vaccines as part of routine care. Blood and urine samples will be collected and tested at different time points to look at how the immune response develops to these vaccines and if there are any differences between people with CKD and those without. This will help us understand how CKD affects the function of the immune system.
Conditions
- Immune System Diseases
- Chronic Kidney Disease
Interventions
- BIOLOGICAL
-
Seasonal influenza and pneumococcal polysaccharide vaccines
Vaccination
Sponsors & Collaborators
-
Wellcome Trust
collaborator OTHER -
University Hospital Birmingham NHS Foundation Trust
collaborator OTHER -
University of Birmingham
lead OTHER
Principal Investigators
-
Lorraine Harper · University of Birmingham
Eligibility
- Min Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-07-31
- Primary Completion
- 2017-08-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine,Formulation 2011-2012, in Dialysis Patients
NCT01512056 ·Status: UNKNOWN ·Phase: PHASE4
-
Seasonal Influenza and Pneumococcal Vaccination in the Elderly
NCT05661890 ·Status: COMPLETED
-
Non-Inferiority Study Comparing the Subunit Vaccines Influvac and Agrippal in China
NCT00325260 ·Status: COMPLETED ·Phase: PHASE3
-
Assess the Risk of Solid Organ Transplant Rejection Following Vaccination With Pandemrix™ in UK
NCT01715792 ·Status: COMPLETED
-
Clinical Study for Safety and Immunogenicity Study of Influenza Vaccine
NCT01617239 ·Status: COMPLETED ·Phase: PHASE1
-
Influenza Immunization in Adults Over Age 75
NCT02200276 ·Status: RECRUITING ·Phase: NA
-
Influenza Vaccination in Hemodialysis Patients and Renal Transplant Recipients
NCT00776750 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the Impact of Time of Vaccination on Response to Influenza Vaccine in Patients With Chronic Renal Failure
NCT06907667 ·Status: RECRUITING ·Phase: NA
-
Elderly Influenza Vaccine Immunogenicity Substudy
NCT00170482 ·Status: COMPLETED
-
The Immunogenicity and Safety of 2013-2014 Seasonal Trivalent Influenza Vaccine
NCT02269852 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Different Doses of Influenza Vaccine in Chronic Hemodialysis Patients
NCT05070494 ·Status: UNKNOWN ·Phase: PHASE4
-
Systems Investigation of Vaccine Responses in Aging and Frailty
NCT05291676 ·Status: RECRUITING ·Phase: PHASE2
-
Study of the Impact of Time of Vaccination on Response to Influenza Vaccine in Kidney Transplant Recipients -ChronoVAX
NCT06088563 ·Status: COMPLETED ·Phase: NA
-
B-cell Immunity to Influenza (SLVP017)- Year 5, 2013
NCT03020537 ·Status: COMPLETED ·Phase: PHASE4
-
Immune Response Study of Influenza Vaccine
NCT01310374 ·Status: COMPLETED
-
A Deep Longitudinal Analysis of Next Generation Influenza Vaccines in Older Adults
NCT05518500 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49
NCT01658800 ·Status: COMPLETED ·Phase: PHASE1
-
Influenza A/H1N1/2009-adjuvanted Vaccine in Renal Disease Patients
NCT01298102 ·Status: COMPLETED ·Phase: PHASE4
-
Improving the Humoral Response to Influenza Vaccine in Lung Transplant Recipients by an Intradermal Strategy
NCT00402805 ·Status: COMPLETED ·Phase: PHASE4
-
Study With Quadrivalent Recombinant Influenza Vaccine (RIV4) in Participants 9 Through 49 Years of Age.
NCT05513053 ·Status: COMPLETED ·Phase: PHASE3
-
The Immunogenicity and Safety of 2012-2013 Trivalent Seasonal Influenza Vaccine
NCT01736709 ·Status: COMPLETED ·Phase: PHASE4
-
Influenza in People With Normal and Weakened Immune Systems
NCT00533182 ·Status: COMPLETED
-
Early Immune Responses to Inactivated Influenza Vaccine: a Pilot Study
NCT01522248 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity Study of Adenovirus-vectored, Intranasal Pandemic Influenza Vaccine.
NCT00755703 ·Status: COMPLETED ·Phase: PHASE1
-
B-cell Immunity to Influenza (SLVP017) - Years 2 (2010) & 3 (2011)
NCT03020498 ·Status: COMPLETED ·Phase: PHASE4